Autobio Diagnostics Co., Ltd.
Industry Group: Healthcare
Country/Region: China
Identifier: SHG:603658
Autobio Diagnostics Co Ltd is a clinical diagnostics company in China. It specializes in research and development, production, marketing and service of clinical diagnostic products, including immunoassay, microbiology and biochemical products. It focuses on the common development of both reagents and instruments. Reagents products include immunoassay, biochemistry, microbiology, and IVD subdivision areas, and instruments include both full automation and semi-automation instruments and systems. Geographically it holds a strong distribution network with thousands of distributors in the Chinese market.
ESG Risk Rating
Ranking
Industry Group (1st = lowest risk)
Healthcare 626 out of 641
Universe
Global Universe 14533 out of 16353
What are the ESG Risk Ratings?
Notice: The information is provided as is, for informational, non-commercial purposes only, does not constitute investment advice and is subject to conditions available in our Legal Disclaimer. They are not directed to, or intended for distribution to or use by India-based clients or users and their distribution to Indian resident individuals or entities is not permitted. Usage of this information is not permitted in any way, unless otherwise agreed in writing. By way of exception, usage of this information is permitted to the rated subject, limited to a single reference to the score on the rated subject’s sustainability webpage or CSR report, mentioning Sustainalytics as a source. For referencing Sustainalytics please consult the Company Guide.
Industry Comparison
Company | ESG Risk Rating | Industry Rank |
---|---|---|
Glaukos Corp. |
20.7
Medium
|
167 out of 641 |
Ambu A/S |
22.3
Medium
|
212 out of 641 |
Integer Holdings Corp. |
25.6
Medium
|
304 out of 641 |
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. |
36.7
High
|
620 out of 641 |
Autobio Diagnostics Co., Ltd. |
37.2
High
|
626 out of 641 |
For corporate professionals interested in direct competitor insights
Sustainalytics' Peer Performance Insights gives an in-depth analysis of your company's ESG strengths and weaknesses compared to your competitors and industry performance. These insights can be used to identify areas of ESG improvement to help inform future management decisions that align with your organization's sustainability goals.
Our Approach to Calculating ESG Risk
The ESG Risk Ratings measure a company's exposure to industry-specific material ESG risks and how well a company is managing those risks.
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues. Our exposure score takes into consideration subindustry and company-specific factors such as its business model.
Autobio Diagnostics Co., Ltd.'s Exposure is Medium
Management
Management refers to how well a company is managing its relevant ESG issues. Our management score assesses the robustness of a company's ESG programs, practices and policies.
Autobio Diagnostics Co., Ltd.'s Management of ESG Material Risk is Weak
How do the ESG Risk Ratings work?
Top Material ESG Issues for Autobio Diagnostics Co., Ltd.
Understand how exposed companies are to specific material ESG issues and how well companies are managing these issues.
What are Material ESG Issues?
Material ESG issues are issues that are considered to be financially material to a given company in a relevant sub-industry.
Controversy Rating
Highest Controversy level that has impacted Autobio Diagnostics Co., Ltd.'s ESG Risk Rating in the last three years
Highest Controversy Level